Nexavar
$8,010.56
200MG COM CAJ C/112
... people are viewing this right now
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Reviews
There are no reviews yet.